All In Biotech

Free tool

FAERS Monitor: Sodium Chloride 0.9% and Potassium Chloride 0.075%

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017648 or its brand name (Sodium Chloride 0.9% and Potassium Chloride 0.075%, Potassium Chloride, Sodium Chloride). Reports on generic versions are filed under their own applications.

Reports

60

Serious

44

73% of reports

Hospitalization

34

Death reported

10

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hypokalaemia10
  • acute kidney injury9
  • dehydration7
  • crohn^s disease6
  • diarrhoea6
  • international normalised ratio increased6
  • pelvic fluid collection6
  • pulmonary embolism6
  • dyspnoea5
  • sepsis5
  • vomiting5
  • atrial fibrillation4
  • infusion site pain4
  • malaise4
  • pneumonia4

Reports by year received

View as table
YearReports
20071
20121
20135
20143
20153
20165
201710
20183
201910
20207
20217
20222
20231
20242

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,099 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
pelvic fluid collectionSignal63012.01404.815,046
infusion site painSignal4108.842.2326
hypokalaemiaSignal1076.043.1668
international normalised ratio increasedSignal673.834.5361
pulmonary embolismSignal622.110.4101
acute kidney injurySignal920.611.3150
dehydrationSignal718.49.299
sepsisSignal515.76.855
atrial fibrillationSignal414.45.638
pneumoniaSignal44.31.77
vomitingSignal53.71.68
diarrhoeaSignal63.31.57
malaiseSignal43.21.24
dyspnoeaSignal53.11.35
crohn^s disease60.00.01,769,129

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.